Skip to main content
Erschienen in: Pediatric Nephrology 8/2019

06.03.2019 | Clinical Quiz

Proteinuria in a patient with Graves’ disease: Questions

verfasst von: Aydilek Dagdeviren Cakir, Nur Canpolat, Seha Saygili, Isin Kilicaslan, Hande Turan, Oya Ercan, Olcay Evliyaoglu

Erschienen in: Pediatric Nephrology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 15-year-old female presented with complaints of palpitation and tremor. On initial physical examination, her height, weight, and body mass index (BMI) were 159 cm (− 0.47 SD), 91 kg (3.95 SD), and 35.9 kg/m2 (3.47 SD), respectively. She had a diffuse goiter (grade 2) without proptosis, lid lag or lid retraction. There was a fine hand tremor. Her heart rate was 100 beats per minute and blood pressure was 130/90 mmHg (> 95th percentile). Other physical examination was unremarkable. Laboratory results showed an elevated free T4 (4.61 [0.82–1.75] ng/dL) and free T3 (17.2 [2.27–4.48] pg/mL) and a suppressed thyroid-stimulating hormone (TSH) (0.006 [0.5–4.33] μIU/mL). Immunological evaluation demonstrated the presence of thyroid antibodies against TSH receptor (TRAB) (17.7 [N 0–1.1] IU/mL), thyroid peroxidase (85 [N < 34] IU/mL), and thyroglobulin (340 [N < 115] IU/mL). Thyroid ultrasonography was compatible with thyroiditis. Hyperthyroidism associated with TRAB positivity suggested Graves’ disease and anti-thyroid treatment with methimazole was started. …
Literatur
1.
Zurück zum Zitat Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the international study of kidney disease in children. Lancet 760:1299–1302CrossRefPubMed Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the international study of kidney disease in children. Lancet 760:1299–1302CrossRefPubMed
2.
Zurück zum Zitat International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef
3.
Zurück zum Zitat Cameron JS (1990) Membranous nephropathy in childhood and its treatment. Pediatr Nephrol 4:193–198CrossRefPubMed Cameron JS (1990) Membranous nephropathy in childhood and its treatment. Pediatr Nephrol 4:193–198CrossRefPubMed
4.
Zurück zum Zitat Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21CrossRefPubMedPubMedCentral Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travel and new roads ahead. Kidney Int 77:765–770CrossRefPubMed Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travel and new roads ahead. Kidney Int 77:765–770CrossRefPubMed
6.
Zurück zum Zitat Cossey LN, Walker PD, Chris PL (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307–2311CrossRefPubMed Cossey LN, Walker PD, Chris PL (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307–2311CrossRefPubMed
7.
Zurück zum Zitat Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V (2015) Antibodies to M-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology 20:572–575CrossRefPubMed Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V (2015) Antibodies to M-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology 20:572–575CrossRefPubMed
8.
Zurück zum Zitat O’Regan, Fong JSC, Kaplan BS, De Chadarevian JP, Lapointe N, Drummond KN (1976) Thyroid antigen -antibody nephritis. Clin Immunol Immunopathol 6:341–346CrossRefPubMed O’Regan, Fong JSC, Kaplan BS, De Chadarevian JP, Lapointe N, Drummond KN (1976) Thyroid antigen -antibody nephritis. Clin Immunol Immunopathol 6:341–346CrossRefPubMed
9.
Zurück zum Zitat Jordan SC, Buckingham B, Sakai R, Olson D (1981) Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 304:1212–1215CrossRefPubMed Jordan SC, Buckingham B, Sakai R, Olson D (1981) Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 304:1212–1215CrossRefPubMed
10.
Zurück zum Zitat Horvath F Jr, Teague P, Gaffney EF, Mars DR, Fuller TJ (1979) Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease. Am J Med 67:901–904CrossRefPubMed Horvath F Jr, Teague P, Gaffney EF, Mars DR, Fuller TJ (1979) Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease. Am J Med 67:901–904CrossRefPubMed
11.
Zurück zum Zitat Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB (1978) Thyroglobulin-anti- thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol 9:327–334CrossRefPubMed Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB (1978) Thyroglobulin-anti- thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol 9:327–334CrossRefPubMed
12.
Zurück zum Zitat Sato Y, Sasaki M, Kan R, Osaku A, Koyama S, Shibayama S, Sato M, Narumiya K, Takagi T, Kojima M (1989) Thyroid antigen-mediated glomerulonephritis in Graves’ disease. Clin Nephrol 31:49–52 Sato Y, Sasaki M, Kan R, Osaku A, Koyama S, Shibayama S, Sato M, Narumiya K, Takagi T, Kojima M (1989) Thyroid antigen-mediated glomerulonephritis in Graves’ disease. Clin Nephrol 31:49–52
13.
Zurück zum Zitat Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, Nozu K, Iijima K, Yoshikawa N (2009) Membranous nephropathy associated with thyroid peroxidase antigen. Pediatr Nephrol 24:605–608 Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, Nozu K, Iijima K, Yoshikawa N (2009) Membranous nephropathy associated with thyroid peroxidase antigen. Pediatr Nephrol 24:605–608
14.
Zurück zum Zitat Sasaki K, Yasuda K, Nakanishi K, Rakugi H, Isaka Y, Yamato M (2014) Membranous nephropathy secondary to Graves’ disease with deposits of thyroid peroxidase in an adult. CEN Case Rep 3:90–93CrossRefPubMed Sasaki K, Yasuda K, Nakanishi K, Rakugi H, Isaka Y, Yamato M (2014) Membranous nephropathy secondary to Graves’ disease with deposits of thyroid peroxidase in an adult. CEN Case Rep 3:90–93CrossRefPubMed
15.
Zurück zum Zitat Keenswijk W, Degraeuwe E, Hoorens A, Dorpe JV, Vande Walle J (2018) A case of Graves’ disease associated with membranoproliferative glomerulonephritis and leukocytoclastic vasculitis. J Pediatr Endocrinol Metab 31(10):1165–1168CrossRefPubMed Keenswijk W, Degraeuwe E, Hoorens A, Dorpe JV, Vande Walle J (2018) A case of Graves’ disease associated with membranoproliferative glomerulonephritis and leukocytoclastic vasculitis. J Pediatr Endocrinol Metab 31(10):1165–1168CrossRefPubMed
16.
Zurück zum Zitat Shimamura Y, Tsushima T, Moniwa N, Hasegawa K, Ogawa Y, Takizawa H (2014) Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves’ disease: a case report. J Med Case Rep 8:305CrossRefPubMedPubMedCentral Shimamura Y, Tsushima T, Moniwa N, Hasegawa K, Ogawa Y, Takizawa H (2014) Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves’ disease: a case report. J Med Case Rep 8:305CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hasnain W, Stillman IE, Bayliss GP (2011) Minimal- change renal disease and Graves’ disease: a case report and literature review. NDT Plus 4:96–98PubMedPubMedCentral Hasnain W, Stillman IE, Bayliss GP (2011) Minimal- change renal disease and Graves’ disease: a case report and literature review. NDT Plus 4:96–98PubMedPubMedCentral
18.
Zurück zum Zitat Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A (1994) Antineutrophil cystoplasmic autoantibody–positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124:986–988CrossRefPubMed Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A (1994) Antineutrophil cystoplasmic autoantibody–positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124:986–988CrossRefPubMed
19.
Zurück zum Zitat D’Cruz D, Chesser AM, Lightowler C, Comer M, Hurst MJ, Baker LR, Raine AE (1995) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34:1090–1091CrossRefPubMed D’Cruz D, Chesser AM, Lightowler C, Comer M, Hurst MJ, Baker LR, Raine AE (1995) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34:1090–1091CrossRefPubMed
20.
Zurück zum Zitat Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A (1996) Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron 74:734–735CrossRefPubMed Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A (1996) Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron 74:734–735CrossRefPubMed
21.
Zurück zum Zitat Lionaki S, Vlachopanos G, Georgalis A, Ziakas P, Gakiopoulou H, Petra C, Boletis J (2013) Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole. Lupus 22:95–98CrossRefPubMed Lionaki S, Vlachopanos G, Georgalis A, Ziakas P, Gakiopoulou H, Petra C, Boletis J (2013) Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole. Lupus 22:95–98CrossRefPubMed
22.
Zurück zum Zitat Wang LC, Tsai WY, Yang YH, Chiang BL (2003) Methimazole-induced lupus erythematosus: a case report. J Microbiol Immunol Infect 36:278–281PubMed Wang LC, Tsai WY, Yang YH, Chiang BL (2003) Methimazole-induced lupus erythematosus: a case report. J Microbiol Immunol Infect 36:278–281PubMed
23.
Zurück zum Zitat Reynolds LR, Bhathena D (1979) Nephrotic syndrome associated with methimazole therapy. Arch Intern Med 139:236–237CrossRefPubMed Reynolds LR, Bhathena D (1979) Nephrotic syndrome associated with methimazole therapy. Arch Intern Med 139:236–237CrossRefPubMed
24.
Zurück zum Zitat Ayalon R, Beck LH (2015) Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30:31–39CrossRefPubMed Ayalon R, Beck LH (2015) Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30:31–39CrossRefPubMed
25.
Zurück zum Zitat Kidney Disease Improving global outcomes (KDIGO) glomerulonephritis work group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274CrossRef Kidney Disease Improving global outcomes (KDIGO) glomerulonephritis work group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274CrossRef
26.
Zurück zum Zitat McQuarrie EP, Stirling CM, Geddes CC (2012) Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence –based therapy. Nephrol Dial Transplant 27:235–242CrossRefPubMed McQuarrie EP, Stirling CM, Geddes CC (2012) Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence –based therapy. Nephrol Dial Transplant 27:235–242CrossRefPubMed
27.
Zurück zum Zitat Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923–924CrossRefPubMed Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923–924CrossRefPubMed
28.
Zurück zum Zitat Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G (2003) Rituximab in idiopathic membranous nephropathy: a one year prospective study. J Am Soc Nephrol 14:1851–1857 Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G (2003) Rituximab in idiopathic membranous nephropathy: a one year prospective study. J Am Soc Nephrol 14:1851–1857
29.
Zurück zum Zitat Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC (2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188–2198 Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC (2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188–2198
30.
Zurück zum Zitat Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Marasà M, Remuzzi G (2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1416–1425 Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A,  Marasà M,  Remuzzi G (2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1416–1425
31.
Zurück zum Zitat Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859–866CrossRefPubMed Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859–866CrossRefPubMed
32.
Zurück zum Zitat Weigle WO, Nakamura RK (1969) Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin. Clin Exp Immunol 4:645–657PubMedPubMedCentral Weigle WO, Nakamura RK (1969) Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin. Clin Exp Immunol 4:645–657PubMedPubMedCentral
33.
Zurück zum Zitat Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A, Baltar J, Fresnedo GF, Martín C, Pons S, Lorenzo D, Bernis C, Arrizabalaga P, Juárez GF, Barrio V, Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A,Vega FF, Praga M(2010) Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21:697–704 Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A,  Baltar J, Fresnedo GF, Martín C, Pons S,  Lorenzo D,  Bernis C, Arrizabalaga P, Juárez GF, Barrio V,  Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A,Vega FF, Praga M(2010) Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21:697–704
34.
Zurück zum Zitat De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (2017) A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol 28:421–430CrossRefPubMed De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (2017) A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol 28:421–430CrossRefPubMed
35.
Zurück zum Zitat Fervenza FC, Sethi S, Specks U (2008) Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3:905–919CrossRefPubMed Fervenza FC, Sethi S, Specks U (2008) Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3:905–919CrossRefPubMed
36.
Zurück zum Zitat Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group (2004) Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int 66:1199–1205CrossRefPubMed Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group (2004) Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int 66:1199–1205CrossRefPubMed
37.
Zurück zum Zitat Bomback AS, Fervenza FC (2018) Membranous nephropathy: approaches to treatment. Am J Nephrol 47:30–42CrossRefPubMed Bomback AS, Fervenza FC (2018) Membranous nephropathy: approaches to treatment. Am J Nephrol 47:30–42CrossRefPubMed
38.
Zurück zum Zitat Malatesta- Muncher R, Eldin KW, Beck LH Jr, Michael M (2018) Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol 33:1089–1092CrossRefPubMed Malatesta- Muncher R, Eldin KW, Beck LH Jr, Michael M (2018) Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol 33:1089–1092CrossRefPubMed
Metadaten
Titel
Proteinuria in a patient with Graves’ disease: Questions
verfasst von
Aydilek Dagdeviren Cakir
Nur Canpolat
Seha Saygili
Isin Kilicaslan
Hande Turan
Oya Ercan
Olcay Evliyaoglu
Publikationsdatum
06.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2019
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-019-04220-y

Weitere Artikel der Ausgabe 8/2019

Pediatric Nephrology 8/2019 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.